Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Punit Makani

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Lancet. Respiratory Medicine|March 5, 2026
Assessing the reversibility of bronchiectasis with deep learning - Authors' replyIsabelle Sermet-Gaudelus, Daan Caudri, Punit Makani, et al.
Annals of the American Thoracic Society|April 13, 2026
Impact of two years of treatment with Elexacaftor/Tezacaftor/Ivacaftor on longitudinal changes in structural lung disease in people with Cystic Fibrosis - Results from the RECOVER trialPaul McNally, Karen Lester, Rachel Cregan, et al.
The Lancet. Respiratory Medicine|October 25, 2025
Effect of elexacaftor-tezacaftor-ivacaftor on bronchial dilatations in adolescents with cystic fibrosis: a multicentre prospective observational studyIsabelle Sermet-Gaudelus, Alexia Letierce, Laureline Berteloot, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Lancet. Respiratory Medicine|March 5, 2026
Assessing the reversibility of bronchiectasis with deep learning - Authors' replyIsabelle Sermet-Gaudelus, Daan Caudri, Punit Makani, et al.
Annals of the American Thoracic Society|April 13, 2026
Impact of two years of treatment with Elexacaftor/Tezacaftor/Ivacaftor on longitudinal changes in structural lung disease in people with Cystic Fibrosis - Results from the RECOVER trialPaul McNally, Karen Lester, Rachel Cregan, et al.
The Lancet. Respiratory Medicine|October 25, 2025
Effect of elexacaftor-tezacaftor-ivacaftor on bronchial dilatations in adolescents with cystic fibrosis: a multicentre prospective observational studyIsabelle Sermet-Gaudelus, Alexia Letierce, Laureline Berteloot, et al.
Pageof 1